Trials / Completed
CompletedNCT01859377
Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Pierre Fabre Medicament · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the systemic exposure to ibuprofen after single oromucosal administration of the test product V0498 and single oral administration of a reference product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | V0498 - A mg | Single oromucosal administration |
| DRUG | Ibuprofen | Single oral administration |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2013-05-21
- Last updated
- 2013-06-24
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01859377. Inclusion in this directory is not an endorsement.